Skip to content
54Gene logo

54Gene

54Gene is a YC Winter 2019 (W19) company. Based in Lagos, LA, Nigeria; LA, Nigeria. Team of 47.

  • Genomics

About 54Gene

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

54Gene builds a genomics research and services platform focused on African genetic data, which is critically underrepresented in global medical databases. The company collects, sequences, and licenses this data to pharmaceutical and research partners developing precision medicines and diagnostics. Its work replaces reliance on datasets drawn almost entirely from European populations, giving drug developers access to genetic diversity that current biobanks lack.

Go-to-market

Pharmaceutical companies, biotech firms, and academic research institutions are the primary customers, engaging through research partnerships and data services agreements.

From the Y Combinator listing

How 54Gene describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Precision medicine for Africans and the global population

We are an African genomics research, services and development company addressing the need to include under-represented African genomic data in research which could lead to medical breakthroughs and new healthcare solutions worldwide.

Facts

Industry
Healthcare / Healthcare -> Consumer Health and Wellness
Location
Lagos, LA, Nigeria; LA, Nigeria
Team size
47
Status
Inactive
Stage
Growth

Founders (3)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works